As of 2025-04-28, the EV/EBITDA ratio of Precigen Inc (PGEN) is -4.87. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. PGEN's latest enterprise value is 411.54 mil USD. PGEN's TTM EBITDA according to its financial statements is -84.59 mil USD. Dividing these 2 quantities gives us the above PGEN EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 8.3x - 12.9x | 10.7x |
| Forward P/E multiples | 14.6x - 20.7x | 19.9x |
| Fair Price | (4.11) - (3.60) | (4.30) |
| Upside | -373.7% - -339.9% | -386.7% |
| Date | EV/EBITDA |
| 2025-04-25 | -4.87 |
| 2025-04-24 | -5.18 |
| 2025-04-23 | -5.28 |
| 2025-04-22 | -4.97 |
| 2025-04-21 | -4.41 |
| 2025-04-17 | -4.48 |
| 2025-04-16 | -4.41 |
| 2025-04-15 | -4.66 |
| 2025-04-14 | -4.52 |
| 2025-04-11 | -4.52 |
| 2025-04-10 | -4.10 |
| 2025-04-09 | -4.48 |
| 2025-04-08 | -3.72 |
| 2025-04-07 | -4.27 |
| 2025-04-04 | -3.96 |
| 2025-04-03 | -4.31 |
| 2025-04-02 | -4.80 |
| 2025-04-01 | -4.64 |
| 2025-03-31 | -4.83 |
| 2025-03-28 | -5.18 |
| 2025-03-27 | -5.35 |
| 2025-03-26 | -5.25 |
| 2025-03-25 | -5.60 |
| 2025-03-24 | -5.98 |
| 2025-03-21 | -5.94 |
| 2025-03-20 | -5.91 |
| 2025-03-19 | -5.87 |
| 2025-03-18 | -5.46 |
| 2025-03-17 | -5.84 |
| 2025-03-14 | -5.91 |
| 2025-03-13 | -5.70 |
| 2025-03-12 | -5.84 |
| 2025-03-11 | -5.70 |
| 2025-03-10 | -5.80 |
| 2025-03-07 | -6.12 |
| 2025-03-06 | -6.15 |
| 2025-03-05 | -6.36 |
| 2025-03-04 | -5.84 |
| 2025-03-03 | -5.46 |
| 2025-02-28 | -5.66 |
| 2025-02-27 | -5.73 |
| 2025-02-26 | -5.94 |
| 2025-02-25 | -5.66 |
| 2025-02-24 | -5.73 |
| 2025-02-21 | -6.29 |
| 2025-02-20 | -6.50 |
| 2025-02-19 | -6.71 |
| 2025-02-18 | -6.67 |
| 2025-02-14 | -6.46 |
| 2025-02-13 | -6.53 |